+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study



Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study



Journal of Hepatology 59(5): 949-956



Hepatitis D virus (HDV) has decreased in Europe, but recent reports indicate a rising trend. We report the epidemiological changes, clinical progress, and effect of treatment on the natural course of HDV infection in Greece during the last 13 years. Prospective data were extracted from the HepNet.Greece Cohort-Study. Since 1997, 4673 chronic HBV (CHB) cases (4527 adults, 146 children) have been followed prospectively. Two thousand one hundred thirty-seven patients were tested for anti-HDV [101 (4.7%) positive]. Anti-HDV testing in Greece decreased significantly (57.0% before 2003, 35.3% thereafter; p<0.001). Anti-HDV prevalence among HBsAg-positives was 4.2%; lower in native Greeks (2.8%) than in immigrants (7.5%) or in children (15.3%; p<0.001). Within 2.3 years of follow-up, HDV occurred in 11/2047 HBsAg-positive patients (2.2 new delta-infected adults and 8.7 children per 1000 HBsAg-positive annually). HDV-positive compared to CHB adults were younger (p=0.035) and had more active and advanced disease at baseline, as indicated by laboratory indices and the higher prevalence of cirrhosis at younger age. During a 4.2-year median observation, significantly more anti-HDV-positive than CHB adults developed a liver-related first event (20.0% vs. 8.5%, p Log-rank=0.014).Treatment was received by 46/90 (51.1%) patients, 40 of them interferon-based. In multivariable analysis, interferon significantly decreased disease progression in HDV-positive patients [HR=0.14 (95% CI: 0.02-0.86; p=0.033)]. In Greece, HDV serology is currently tested in only one-third of HBsAg-positive patients. HDV prevalence is lower in native Greeks compared to immigrants, who may contribute >50% of the HDV infection burden in Greece. Data show that HDV infection is a rapidly progressive disease, but interferon-based treatment may alter its course.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055149262

Download citation: RISBibTeXText

PMID: 23850875

DOI: 10.1016/j.jhep.2013.07.005


Related references

Prevalence And Clinical Course Of Hepatitis Delta Infection In Gree A 13-Year Prospective Study. 2013

Low prevalence of HCV, HIV, and HTLV-I/II infection markers in northwestern Greece: results of a 3-year prospective donor study (1995-1997). European Journal of Internal Medicine 14(1): 39-44, 2003

Role of hepatitis C virus in acute non-A, non-B hepatitis in Greece: a 5-year prospective study. Gastroenterology 102(3): 969-972, 1992

Prevalence of hepatitis G virus infection in a French prospective study on low prevalence of post transfusion hepatitis C. Hepatology 24(4 Part 2): 230A, 1996

Higher rates of chronic hepatitis B infection and low vaccination-induced protection rates among parturients escaping HBsAg prenatal testing in Greece: a 2-year prospective study. European Journal of Gastroenterology and Hepatology 24(8): 878-883, 2012

Prevalence of hepatitis delta (delta) virus infection. A seroepidemiologic study. Western Journal of Medicine 148(3): 307-309, 1988

Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients with unusual clinical pictures. Hepatitis Monthly 13(8): E6731, 2013

The prevalence of hepatitis C and hepatitis G virus infection in patients with B cell non-Hodgkin lymphomas in Greece: a Hellenic Cooperative Oncology Group Study. Acta Haematologica 112(4): 189-193, 2004

Why most patients with hepatitis delta virus infection are seronegative for hepatitis B e antigen. A prospective controlled study. Journal of Hepatology 12(1): 106-109, 1991

Coinfection of hepatitis B and hepatitis delta virus in Belgium: a multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection. Journal of Medical Virology 85(9): 1513-1517, 2013

The prevalence and clinical characteristics of hepatitis-delta infection in Korea. Korean Journal of Hepatology 11(1): 43-50, 2005

Prevalence of chronic HBV infection among 13,581 women at reproductive age in Greece. A prospective single center study. Journal of Clinical Virology 32(2): 179-180, 2005

Delta infection in asymptomatic carriers of hepatitis B surface antigen: low prevalence of delta activity and effective suppression of hepatitis B virus replication. Hepatology 8(5): 1121-1124, 1988

Prevalence and clinical features of hepatitis delta virus infection in the Miyako Islands, Okinawa, Japan. Journal of Gastroenterology 33(6): 850-854, 1998